Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed about the loss of share certificate(s) received details as enclosed. The company is in the process of issuing duplicate share certificate, after compliance of required formalities. The company has informed the members of the Exchange, with instructions that they communicate to them immediately if they are in a position to give them information relating to any transaction or whereabouts of the above referred original share certificate.
The above information is a part of company’s filings submitted to BSE.
